BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3731730)

  • 1. Burkitt leukaemia following chemoradiotherapy in a patient with Hodgkin's disease.
    Brenner B; Nagler A; Ben-Arieh Y; Steiner M
    Clin Lab Haematol; 1986; 8(2):163-4. PubMed ID: 3731730
    [No Abstract]   [Full Text] [Related]  

  • 2. Hodgkin's disease, splenectomy and secondary leukemia.
    Centurioni R; Brianzoni F; Leoni P; Danieli G
    Haematologica; 1993; 78(4):258-9. PubMed ID: 8294062
    [No Abstract]   [Full Text] [Related]  

  • 3. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease.
    N Engl J Med; 1987 Sep; 317(11):707-9. PubMed ID: 3627177
    [No Abstract]   [Full Text] [Related]  

  • 5. Carcinogenesis in Hodgkin's disease.
    Colman M
    Hematol Oncol; 1984; 2(1):2-4. PubMed ID: 6588020
    [No Abstract]   [Full Text] [Related]  

  • 6. Second malignancy complicating Hodgkin's disease.
    Tawil E; Mercier JP
    J Can Assoc Radiol; 1983 Jun; 34(2):108-13. PubMed ID: 6688422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Burkitt lymphoma].
    Santoro G; Rocco P
    G Chir; 1996; 17(8-9):405-7. PubMed ID: 9004834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Low grade non-Hodgkin's lymphoma after combined therapy for Hodgkin's disease].
    Raya Sánchez JM; González Brito G; Hernández Nieto L; Brito Barroso ML; Alvarez Argüelles H; Jorge Hernández JA; Martín Herrera A
    Sangre (Barc); 1994 Dec; 39(6):461-4. PubMed ID: 7855699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myeloid leukemia following therapy of Hodgkin's disease with radiotherapy and ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine).
    Lipton JH; Gospodarowicz M; Reingold S
    Hematol Oncol; 1996 Mar; 14(1):29-31. PubMed ID: 8613133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Second tumors following treatment of Hodgkin's disease].
    Somers R; van Leeuwen FE; Taal BG; van Heerde P; Coster B; Hart AA
    Ned Tijdschr Geneeskd; 1988 Jul; 132(29):1358-62. PubMed ID: 3412505
    [No Abstract]   [Full Text] [Related]  

  • 11. New therapies in Hodgkin's lymphoma.
    Bartlett N
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):80, 83. PubMed ID: 16163165
    [No Abstract]   [Full Text] [Related]  

  • 12. [Burkitt-type lymphoma following Hodgkin's disease].
    Andrieu JM; Casassus P; Bayle-Weisgerber C; Preud'homme JL; Berger R; Flandrin G
    Nouv Presse Med; 1980 Apr; 9(16):1175. PubMed ID: 7367276
    [No Abstract]   [Full Text] [Related]  

  • 13. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
    Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
    Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A patient with acute non-lymphatic leukemia 2 years after non-Hodgkin's lymphoma].
    De Witte T; Muus P; De Pauw B; Haanen C
    Ned Tijdschr Geneeskd; 1988 Jul; 132(27):1260. PubMed ID: 3398964
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acute non-lymphoblastic leukosis as a second neoplasm in Hodgkin's disease].
    Díaz Pérez MA; Zamora Auñón P; Escobar Alvarez Y; García de Parecdes ML
    Med Clin (Barc); 1985 Feb; 84(4):167. PubMed ID: 3982119
    [No Abstract]   [Full Text] [Related]  

  • 16. The lymphomas: an update for surgeons.
    Whalen TV; La Quaglia MP
    Semin Pediatr Surg; 1997 Feb; 6(1):50-5. PubMed ID: 9117275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy and radiotherapy in Hodgkin's lymphoma: joining in or splitting up?
    van der Maazen RW; Raemaekers JM
    Curr Opin Oncol; 2006 Nov; 18(6):660-6. PubMed ID: 16988591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the therapy of Hodgkin's disease in elderly patients. The Piemonte Hodgkin's Disease Register (PHDR).
    Levis A
    Hematol Oncol; 1993; 11 Suppl 1():78-84. PubMed ID: 7683625
    [No Abstract]   [Full Text] [Related]  

  • 19. The chemotherapy/radiation balance in advanced Hodgkin's lymphoma: overweight which side?
    Carde P
    J Clin Oncol; 2005 Dec; 23(36):9058-62. PubMed ID: 16314611
    [No Abstract]   [Full Text] [Related]  

  • 20. [Aseptic femur head necrosis following chemoradiotherapy of lymphogranulomatosis].
    Gun'ko RI; Bardychev MS
    Med Radiol (Mosk); 1989 Apr; 34(4):73-6. PubMed ID: 2709967
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.